1. News & Events
  2. Blog

Blog

nPhase closes on its first round of funding

Two new Vanderbilt technologies earn patent protection

Two new Vanderbilt technologies earn patent protection in December.

9,207,196      Transmission electron microscopy for imaging live cells

CTTC co-hosts technology in healthcare event

Pictured left to right: Pearl Freier, Cambridge BioPartners; Hassan Naqvi, Vanderbilt CTTC; Jordan Asher, MissionPoint Health Partners; Kevin Johnson, Vanderbilt; Jim Lancaster, Cigna; Drew Ladner, Pascal Metrics; Tom Lloyd, Capgemini North America; Bill Taranto, Merk GHI

Five new Vanderbilt technologies earn patent protection in November

Five new Vanderbilt technologies earn patent protection in November.

9,192,603 Heterocyclic sulfone mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction

TCS and Vanderbilt University Medical Center partner to advance healthcare and life sciences research

Tata Consultancy Services (BSE: 532540, NSE: TCS), a leading global IT services, consulting and business solutions organization, announced a new partnership with Vanderbilt University Medical Center (VUMC) to drive innovation in the healthcare and life sciences fields.

VEN: Investor Perspectives Panel Session

Vanderbilt Entrepreneurial Network Presents Investor Perspective Panel Session

Get ready for a special panel session this week featuring 4 real-world investors at all stages of the investment food chain on Thursday 11/4 at 5:30pm in 136 Featheringill Hall! Here’s a preview of what’s ahead: Week 7 Preview (Nov 4th): Investor Perspectives Want to know how investors think, and how the investment food chain works? Come on down! Panelists include:

Two Vanderbilt technologies earned patent protection in October

Two new Vanderbilt technologies earned patent protection in Octoberr.

 

HERMES Medical Solutions and Vanderbilt University announce exclusive license and commercialization agreement

HERMES Medical Solutions (HERMES) by Sofia Bertling COO and Vanderbilt University (Vanderbilt) by Professor Michael Stabin announced today the signature of an exclusive license and commercialization agreement for the new dosimetry application OLINDA / EXM® to be distributed by HERMES.

Five Vanderbilt technologies earned patent protection in September

Five Vanderbilt technologies earned patent protection in September.

9,140,705   Tumor suppressor killin

PinPtr and VenoStent win the NSF Accelerating Innovation Research - Technology Translation Grant

Two Vanderbilt technologies, PinPtr (high-precision, low-cost GPS cloud service) and VenoStent (stent to prevent intimal hyperplasia) have been awarded the coveted National Science Foundation Accelerating Innovation Research - Technology Translation (AIR-TT) grant of approximately $200,000 (each). PinPtr is led by Dr. Akos Ledeczi, Associate Professor and Senior Research Scientist and Dr.